✦ LIBER ✦

Bone-forming ability of 24r,25-dihydroxyvitamin d3 in the hypophosphatemic mouse

✍ Scribed by Tomoo Yamate; Hiroyuki Tanaka; Yumiko Nagai; Hideyuki Yamato; Nobuyuki Taniguchi; Toshitaka Nakamura; Yoshiki Seino

Book ID: 112119371
Publisher: American Society for Bone and Mineral Research
Year: 2009
Tongue: English
Weight: 837 KB
Volume: 9
Category: Article
ISSN: 0884-0431
DOI: 10.1002/jbmr.5650091217

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

24R,25-Dihydroxyvitamin D3increases bone

24R,25-Dihydroxyvitamin D3increases bone mass in vivo

✍ T. Nakamura 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 451 KB

Effect of estrogen/gestagen and 24R,25-d

Effect of estrogen/gestagen and 24R,25-dihydroxyvitamin D3 therapy on bone formation in postmenopausal women

✍ Dr. Karsten Thomsen; Bente Riis; Claus Christiansen 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 348 KB

Effects of 1α-hydroxyvitamin D3and 24R,2

Effects of 1α-hydroxyvitamin D3and 24R,25-dihydroxyvitamin D3on bone remodeling

✍ K. Galus; J. Szymendera; A. Zaleski; K. Schreyer 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 354 KB

Synthesis of active forms of vitamin D V

Synthesis of active forms of vitamin D VI synthesis of (24R)- and (24S)-24,25-dihydroxyvitamin D3

✍ Masao Seki; Naoyuki Koizumi; Masuo Morisaki; Nobuo Ikekawa 📂 Article 📅 1975 🏛 Elsevier Science 🌐 French ⚖ 208 KB

Fluorometric assay of 25-hydroxyvitamin

Fluorometric assay of 25-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 in plasma

✍ Masato Shimizu; Ying Gao; Takeshi Aso; Koji Nakatsu; Sachiko Yamada 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Abnormal modulation of serum osteocalcin

Abnormal modulation of serum osteocalcin by dietary phosphate and 1,25-dihydroxyvitamin D3 in the hypophosphatemic mouse

✍ H. Tsuji; C. Cawthorn; B. Ecarot 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 712 KB

We evaluated in normal and hypophosphatemic (Hyp) mice whether changes in serum levels of osteocalcin in response to dietary phosphate supplementation, parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D, (1,25(OH),D,) administration were related to perturbations in calcium phosphate homeostasis.